NEJM Evid February 2024 PMID 38320489

Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure.

Stefan James, David Erlinge, Robert F Storey, Darren K McGuire, Mark de Belder, Niclas Eriksson, Kasper Andersen, David Austin, Gabriel Arefalk, David Carrick, Robin Hofmann, Stephen P Hoole, Daniel A Jones, Kelvin Lee, Hans Tygesen

Full text PDF Download social card

Mentions

180

Peak: 131 in Nov 2023

across 4 sources since Nov 2023

Extended reach

1,761,677

potential audience

Total likes

543

Video views

1,859

Mentions per month

Nov 2023 – May 2025

Where it's discussed

X / Twitter163 posts
News12 articles
YouTube3 videos
Facebook2 posts

AI synopsis

What people are saying

Many participants reference specific outcomes of the DAPA-MI trial, such as the notable ‘win ratio’ obtained in the efficacy analysis. Additionally, some discussions emphasize safety and suggest the study could reshape therapeutic approaches, using phrases like 'must consider' and 'significant implications' to underscore the importance of the findings.

AgreementModerate agreement

The majority of discussions support the study's methodology and findings, expressing a general understanding of its significance.

InterestHigh interest

There is a high level of fascination, with many discussing its relevance in current clinical practices and implications for patient care.

EngagementModerate engagement

While many posts provide summaries and references, deeper analysis is less common, suggesting moderate engagement with the findings.

ImpactHigh impact

Discussions indicate a belief that the publication could have considerable effects on treatment protocols and future research.

Abstract in brief

The study evaluated the effects of dapagliflozin in patients with acute myocardial infarction (MI) who had impaired heart function but no prior diabetes or chronic heart failure.
Over 4,000 patients were enrolled, with those taking dapagliflozin showing a significant improvement in a composite outcome of various adverse events compared to the placebo group.
Despite these improvements in cardiometabolic outcomes, there was no significant difference in rates of cardiovascular death or hospitalization for heart failure between the two groups, and safety concerns were not identified.

Read the full abstract

All mentions

ESC Guidelines for Cardiovascular Diseases in Diabetes Management

Prof. Dr. Nikolaus Marx and Prof. Dr. Harald Sourij discuss the 2023 ESC guidelines for treating cardiovascular diseases in diabetes Mellitus, presented at the ESC congress and published in the European Journal of…

MARKUS at HOMe · Dec 1, 2023 1,694 views

Top Clinical Papers of November 2023 in Cardiology

Join our scientific team as we discuss the three most impactful clinical papers of November 2023. This month’s highlights include a study on dapagliflozin in myocardial infarction without diabetes, showcasing its…

Medical Portfolio APP · Dec 12, 2023 128 views

Cardiology Advances: Dapagliflozin's Impact Post-Myocardial Infarction

Medscape · Mar 27, 2024 38 views

Pharmacy Residency

@PGYpharmacy · X

Academic activity

May 31, 2025 · 6 likes · 1 share · 367 followers View post →

Tom Hsiung

@TomHsiung · X

Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure | NEJM Evidence https://t.co/Y6zhUGCgHV

Feb 28, 2025 · 462 followers View post →

J. Eulert-Grehn , MD

@EulertJ · X

RT @kaulcsmc: DAPA-MI A case of 'divining' a positive outcome with 'misuse' of Win Ratio! PEP driven by most prevalent but arguably least…

Jan 15, 2025 · 18 shares · 1,906 followers View post →

Rhys Williams

@RhysWMPharm · X

@PharmacistHF https://t.co/ckQ78UohJF https://t.co/GOeIxpDuhG https://t.co/cXcMFJOrca

Jun 19, 2024 · 1 like · 1,197 followers View post →

Uppsala Antibiotic Center

@UAC_UU · X

RT @u_eson: A nice example of a RRCT, with multi-country involvement and sophisticated digital solutions, published at https://t.co/2as4Epc…

May 29, 2024 · 1 share · 2,347 followers View post →

Ulf Emanuelson

@u_eson · X

A nice example of a RRCT, with multi-country involvement and sophisticated digital solutions, published at https://t.co/2as4EpciE9 #UADays24

May 29, 2024 · 2 likes · 1 share · 535 followers View post →

吉田晃三

@kozoyoshida · X

RT @Toki_nd2525: DAPA-MIかな　気になっていたやーつ頭を整理 Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure https://t.co/H1rSfOAK…

Apr 10, 2024 · 2 shares · 3,494 followers View post →

unimusashi（N. Ashikawa）

@uni_pharmacist · X

RT @Toki_nd2525: DAPA-MIかな　気になっていたやーつ頭を整理 Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure https://t.co/H1rSfOAK…

Apr 9, 2024 · 2 shares · 1,333 followers View post →

ちろ剤師★薬物療法ニキ

@Toki_nd2525 · X

DAPA-MIかな　気になっていたやーつ頭を整理 Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure https://t.co/H1rSfOAKdq 慢性心不全や糖尿病の既往のないAMI患者に対するダパグリフロジンの効果についての検討。 https://t.co/egJFCjZXJf

Apr 9, 2024 · 8 likes · 2 shares · 5,757 followers View post →

循環器病薬剤師ネットワーク(#循薬ネット)

@Cardio_Pharm_JP · X

RT @Cardio_Pharm_JP: 【対象論文】 Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure NEJM Evid. 2024 Feb;3(2) PMID: 383204…

Apr 8, 2024 · 1 share · 4,405 followers View post →

Arnel Carmona

@ecgrhythms · X

RT @AimanSmer: #MedTwitter #ACC2024 Consistent results for the prophylactic use of #SGLT2i in Post MI.! Based on DAPA-MI & EMPACT-MI t…

Apr 7, 2024 · 1 share · 27,639 followers View post →

Aiman Smer

@AimanSmer · X

#MedTwitter #ACC2024 Consistent results for the prophylactic use of #SGLT2i in Post MI.! Based on DAPA-MI & EMPACT-MI trials, both Dapagliflozin & Empagliflozin Post MI Did Not Lower the Risk of HF Hospitalization or Death! https://t.co/B0cD6kzPVm https://t.co/DIWTHkkMeF https://t.co/BKatyJB1hW https://t.co/BTB33IGOwV

Apr 7, 2024 · 4 likes · 1 share · 893 followers View post →

ちろ剤師★薬物療法ニキ

@Toki_nd2525 · X

cardiometabolic outcomes には良かったみたい　心血管死や再入院は変わらへんてことかな予習 https://t.co/9XZPx2MuLZ

Mar 17, 2024 · 3 likes · 5,757 followers View post →

循環器病薬剤師ネットワーク(#循薬ネット)

@Cardio_Pharm_JP · X

【対象論文】 Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure NEJM Evid. 2024 Feb;3(2) PMID: 38320489 DOI: 10.1056/EVIDoa2300286 https://t.co/zDZ4wUs7Lo

Mar 16, 2024 · 4 likes · 1 share · 4,405 followers View post →

Chidambara .ML.

@chidambara09 · X

RT @NEJMEvidence: Original Article: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD, et…

Feb 20, 2024 · 1 share · 11,712 followers View post →

NEJM Evidence

@NEJMEvidence · X

Original Article: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD, et al.: https://t.co/IkPXE5ixxB #cardiology https://t.co/g1SMoDyHnO

Feb 20, 2024 · 4 likes · 1 share · 30,915 followers View post →

Royal Papworth Hospital Library

@RoyalPapLib · X

#papworthauthors new publication: Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure. https://t.co/H4fdoxG2hZ #Dapagliflozin #MyocardialInfarction @hoole_stephen @royalpapworth @royalpapres

Feb 19, 2024 · 1 like · 1,027 followers View post →

Tom Hsiung

@TomHsiung · X

Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure | NEJM Evidence https://t.co/fESmUxTKLm

Feb 8, 2024 · 462 followers View post →

Flotta Dura Senza Paura

@flottadura · X

RT @NEJMEvidence: In patients with acute myocardial infarction, after 1 year of treatment with dapagliflozin, there were significant benefi…

Jan 24, 2024 · 12 shares · 314 followers View post →

NEJM Evidence

@NEJMEvidence · X

In patients with acute myocardial infarction, after 1 year of treatment with dapagliflozin, there were significant benefits with regards to improvement in cardiometabolic outcomes but no impact on cardiovascular death/hospitalization for heart failure. https://t.co/IkPXE5hZI3 https://t.co/6AO9PRle5k

Jan 24, 2024 · 27 likes · 12 shares · 30,915 followers View post →

宇津貴史 /Utsu, Takashi

@Office_j · X

【追記】 DAPA-MI、印刷版出来。 NEJM Evid https://t.co/gMaVDb9hxd [Free] https://t.co/o85yP5w8sm https://t.co/cdpVsEbwKe

Jan 23, 2024 · 4 likes · 4,901 followers View post →

ThL

@lpt125 · X

RT @aklfahed: DAPA-MI #AHA2023 Dapagliflozin in secondary CVD prevention Patients post acute MI + impaired LVEF but no DM/HF Registry-b…

Dec 28, 2023 · 2 shares · 47 followers View post →

Prof Chris P Gale

@cpgale3 · X

https://t.co/Rr3mvFSUnF

Dec 15, 2023 · 1 like · 13,469 followers View post →

みや

@1ch1go1ch1e · X

RT @TEUrsbX1CWKJHnJ: 個人的にこの論文はかなり評価低いんですが、なんで載ったん？エンドポイントが恣意的で卑怯だろ。 Dapagliflozin in Myocardial Infarction without Diabetes or Heart Fai…

Dec 12, 2023 · 3 shares · 3,540 followers View post →

名前

@akkiii0830 · X

Dec 12, 2023 · 3 shares · 246 followers View post →

いつの間にか老害ドクター

@TEUrsbX1CWKJHnJ · X

個人的にこの論文はかなり評価低いんですが、なんで載ったん？エンドポイントが恣意的で卑怯だろ。 Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure | NEJM Evidence https://t.co/9HrNDnJ9kV

Dec 11, 2023 · 16 likes · 3 shares · 7,303 followers View post →

Dr. Pedro A. Carrillo Moreno

@cardiodocpedro · X

Dec 7, 2023 · 4,253 followers View post →

Nicolás Martinez Marietti

@Nicommarietti · X

DAPA - MI trial

Dec 6, 2023 · 7 likes · 106 followers View post →

Nisha Nigil

@nishanigil · X

In patients with acute MI , after 1 year of treatment with dapagliflozin there were significant benefits with regard to improvement in cardiometabolic outcomes but no impact on the composite of CV or hospitalization for heart failure compared with placebo.https://t.co/m7dAoFosFF

Dec 6, 2023 · 1,588 followers View post →

Illuminate131

@Illuminate75601 · X

RT @KagiyamaNobu: DAPA-MI ようやくちゃんとみたけど **DMがなくてHFがないAMI患者**はほとんど（2.5%くらいしか）心不全入院しないんですね、、、心不全をケアするのはもちろん大事だが、むしろ他のところ気をつけた方が良さそう https:…

Dec 4, 2023 · 2 shares View post →

Takuya Kishi @ねこ好き循環器内科医

@tkishi_cardiol · X

Dec 3, 2023 · 2 shares · 14,686 followers View post →

Nobu Kagiyama@Heart doctor

@KagiyamaNobu · X

Dec 3, 2023 · 46 likes · 2 shares · 7,026 followers View post →

T.kimura

@jjcrazydiamond · X

RT @NEJMEvidence: In the DAPA-MI trial, 4017 patients w/ acute MI were randomized to daily dapagliflozin or placebo for 1 year. The analysi…

Nov 20, 2023 · 20 shares · 1,367 followers View post →

Чиж

@rough_fiddle · X

RT @NEJMEvidence: In the DAPA-MI trial, 4017 patients w/ acute MI were randomized to daily dapagliflozin or placebo for 1 year. The analysi…

Nov 20, 2023 · 20 shares · 9 followers View post →

@investigando

@rocatanho · X

En pacientes con IM agudo, luego de 1a de tratamiento con dapagliflozina hay beneficios con respecto a la mejoría de los eventos cardiometabólicos sin impacto en las muertes por causas CV u hospitalización por insuficiencia cardíaca #dapagliflozina #MI https://t.co/bC84qLUb38

Nov 20, 2023 · 400 followers View post →

NEJM Evidence

@NEJMEvidence · X

Nov 20, 2023 · 42 likes · 20 shares · 30,915 followers View post →

Tom Hsiung

@TomHsiung · X

Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure | NEJM Evidence https://t.co/LPiBICiRVX

Nov 16, 2023 · 462 followers View post →

Chidambara .ML.

@chidambara09 · X

RT @AAlMohammad87: Interesting @NEJM: #DAPA_MI trial did not show reduction in death/HHF. Compared to #DAPA_HF/ #DELIVER, could we say what…

Nov 15, 2023 · 1 share · 11,712 followers View post →

Chidambara .ML.

@chidambara09 · X

RT @AAlMohammad87: #DAPA_CKD did lead to significant impact on #MACE: Could that have been due to the CKD? When asymptomatic LVSD after #MI…

Nov 15, 2023 · 1 share · 11,712 followers View post →

Abdallah Al-Mohammad

@AAlMohammad87 · X

#DAPA_CKD did lead to significant impact on #MACE: Could that have been due to the CKD? When asymptomatic LVSD after #MI did not do the same @NEJM with #DAPA_MI? #CardioTwitter @BSHeartFailure @markcpetrie20 https://t.co/HgcoikcHcH

Nov 15, 2023 · 1 share · 926 followers View post →

Abdallah Al-Mohammad

@AAlMohammad87 · X

Interesting @NEJM: #DAPA_MI trial did not show reduction in death/HHF. Compared to #DAPA_HF/ #DELIVER, could we say what matters is #HF syndrome (not asymptomatic LVSD)? @BSHeartFailure @markcpetrie20 #CardioTwitter @HFA_President https://t.co/HgcoikcHcH

Nov 15, 2023 · 5 likes · 1 share · 926 followers View post →

宇津貴史 /Utsu, Takashi

@Office_j · X

【MI後左室機能低下例に対するSGLT2-i：大規模RCT/ NEJM Evid】 MI後左室機能低下の非DM 4017例ランダム化、約１年観察：「死亡→HF入院→MI→ AF・・・」抑制 Win-ratioはSGLT2阻害薬群でプラセボに対し1.34 [95%CI 1.20-1.50]。なお「死亡・HF入院」発生率に群間差なし。 https://t.co/NdZbV5bRAC

Nov 14, 2023 · 13 likes · 4,901 followers View post →

Francisco Pesantez VILLACIS

@Ab_Fco_Pesantez · X

RT @LuisZuritaG: Dapagliflozina en el infarto de miocardio sin diabetes ni insuficiencia cardíaca | Evidencia de NEJM https://t.co/NqWGk4FN…

Nov 14, 2023 · 1 share · 1,536 followers View post →

Luis Zurita G.

@LuisZuritaG · X

Dapagliflozina en el infarto de miocardio sin diabetes ni insuficiencia cardíaca | Evidencia de NEJM https://t.co/NqWGk4FNlA

Nov 14, 2023 · 1 like · 1 share · 6,431 followers View post →

Carolina Manzur

@CarolinaManzurB · X

Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure | NEJM Evidence https://t.co/Ric2jeHqh0

Nov 14, 2023 · 3 likes · 698 followers View post →

nguyenlehoangphung

@nguyenphung217 · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 13, 2023 · 27 shares · 22 followers View post →

nguyenlehoangphung

@nguyenphung217 · X

RT @SeguraCardio:

Nov 13, 2023 · 25 shares · 22 followers View post →

Dr David Austin

@akaplatini · X

Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure | NEJM Evidence https://t.co/XcBIdDGaBq

Nov 13, 2023 · 7 likes · 145 followers View post →

Dr_Flutter

@Dr_Quirino · X

RT @SeguraCardio:

Nov 12, 2023 · 25 shares · 59 followers View post →

Jorge Demartino

@JorgeDemartino1 · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 314 followers View post →

magisterlusor

@MagisterLusor · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 146 followers View post →

Javed Butler

@JavedButler1 · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 6,594 followers View post →

Bala Tangiisuran

@DrTangiisuran · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 283 followers View post →

EOLO MORANDI JR.

@eolojr · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 538 followers View post →

Dr Gabriel Parma. Profesor adjunto de cardiologia

@parma315 · X

RT @SeguraCardio:

Nov 12, 2023 · 25 shares · 772 followers View post →

CardioAcademic

@CardioAcademic · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 3,220 followers View post →

Jean-Luc Vachiery

@jeanlucvachiery · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 1,270 followers View post →

havez

@ChavezHuaylla · X

RT @SeguraCardio:

Nov 12, 2023 · 25 shares · 84 followers View post →

Takuya Kishi @ねこ好き循環器内科医

@tkishi_cardiol · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 14,686 followers View post →

Alejandro I. Pérez Cabeza

@alejandroipc2 · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 1,164 followers View post →

Professor Scott Wright

@ScottWrightMD · X

RT @kaulcsmc: DAPA-MI A case of 'divining' a positive outcome with 'misuse' of Win Ratio! PEP driven by most prevalent but arguably least…

Nov 12, 2023 · 18 shares · 1,388 followers View post →

Paul Forsyth

@PharmacistHF · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 3,741 followers View post →

Jorge Sánchez Cantillo

@DrJorgeSanchezC · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 126 followers View post →

Karl Dujardin

@KDujardin · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 634 followers View post →

Dr. Osmar Perez S.

@osmarperse · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 2,457 followers View post →

Giuseppe Galati

@GiuseppeGalati_ · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 10,459 followers View post →

Francesco Paneni

@FrancescoPaneni · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 1,213 followers View post →

Dr joe_seth

@joemoyambi2 · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 837 followers View post →

MedEd Global Solutions

@global_meded · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 243 followers View post →

Dr. Shashank Joshi

@AskDrShashank · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 32,514 followers View post →

Umut Kocabaş

@UmutKocabasMD · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 1,458 followers View post →

Michele Emdin

@MicheleEmdin · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 1,016 followers View post →

Chidambara .ML.

@chidambara09 · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 11,712 followers View post →

adagajak

@zftjhust · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 202 followers View post →

Josh J Park, PharmD, BCCP

@joshuvastatin · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 235 followers View post →

Seba GZ, MD, MSc

@sebagz1 · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 1,634 followers View post →

Juan Carlos Obaya

@jcobaya69 · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 856 followers View post →

Dr.Swarup De MD

@swarup_de2020 · X

Dapagliflozin 10mg showing promising results on Type 2 DM in a case of Acute STEMI followed by Primary PCI https://t.co/iD6IHsH5QZ

Nov 12, 2023 · 1 like · 183 followers View post →

Natsir Ramadhan

@natsiradhan · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 558 followers View post →

Nicolas Manito

@Dr_Manito · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 5,469 followers View post →

Tomasz Jurga

@JurgaTomek · X

This was an extremely ambitious study. No wonder DAPA-MI wasn't even able to initially reach required power after excluding those with typically high ASCVD risk. Personally, I find the shift to a win ratio method curious. Win from a metabolic point only. https://t.co/gLZVqC5etP

Nov 12, 2023 · 5 likes · 335 followers View post →

Ritu Thamman MD

@iamritu · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 31,669 followers View post →

Giuseppe Biondi-Zoccai

@gbiondizoccai · X

RT @GiuseppeGalati_: ❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 37 shares · 12,126 followers View post →

Giuseppe Galati

@GiuseppeGalati_ · X

❌ #DAPA_MI #AHA2023 1st Disappointing result for #dapa >4000 #AMI Only 2 nations

Nov 12, 2023 · 79 likes · 37 shares · 10,459 followers View post →

Nicholas Lim, MD

@nicholasnlim · X

RT @SeguraCardio:

Nov 12, 2023 · 25 shares · 571 followers View post →

Manuel Gaxiola

@cardiogax · X

RT @CristobMorales: https://t.co/WX2zJrTTGH DAPAGLIFLOZIN IN MYOCARDIAL INFARCTION WITHOUT DIABETES OR HEART FAILURE @AHA23 @ValleAlfonso @…

Nov 12, 2023 · 12 shares · 7,984 followers View post →

Paco Ruiz Herrera

@PacoRuizHerrera · X

RT @SeguraCardio:

Nov 12, 2023 · 25 shares · 5 followers View post →

Rodrigo Nunes Cal

@CalZole · X

RT @SeguraCardio:

Nov 12, 2023 · 25 shares · 3,996 followers View post →

M. Fernanda Ramirez S. MD

@mframirezs1973 · X

RT @SeguraCardio:

Nov 12, 2023 · 25 shares · 1,100 followers View post →

Martín López de la Torre

@elendocrino · X

RT @CristobMorales: https://t.co/WX2zJrTTGH DAPAGLIFLOZIN IN MYOCARDIAL INFARCTION WITHOUT DIABETES OR HEART FAILURE @AHA23 @ValleAlfonso @…

Nov 12, 2023 · 12 shares · 2,950 followers View post →

Nahir Betzabeth

@Nahir3hen · X

RT @CristobMorales: https://t.co/WX2zJrTTGH DAPAGLIFLOZIN IN MYOCARDIAL INFARCTION WITHOUT DIABETES OR HEART FAILURE @AHA23 @ValleAlfonso @…

Nov 12, 2023 · 12 shares · 153 followers View post →

DANIEL CROCE

@danicroce2015 · X

RT @CristobMorales: https://t.co/WX2zJrTTGH DAPAGLIFLOZIN IN MYOCARDIAL INFARCTION WITHOUT DIABETES OR HEART FAILURE @AHA23 @ValleAlfonso @…

Nov 12, 2023 · 12 shares · 12 followers View post →

MedEd Global Solutions

@global_meded · X

RT @kaulcsmc: DAPA-MI A case of 'divining' a positive outcome with 'misuse' of Win Ratio! PEP driven by most prevalent but arguably least…

Nov 12, 2023 · 18 shares · 243 followers View post →

Miriam Sandín

@miriamsandin · X

RT @CristobMorales: https://t.co/WX2zJrTTGH DAPAGLIFLOZIN IN MYOCARDIAL INFARCTION WITHOUT DIABETES OR HEART FAILURE @AHA23 @ValleAlfonso @…

Nov 12, 2023 · 12 shares · 3,012 followers View post →

Loren Villalobos

@LorenVillato · X

@Gustavo22205004 @jpcostabel https://t.co/61Qi8Dys7m

Nov 12, 2023 · 282 followers View post →

Bartosz Hudzik MD PhD FESC FACC

@BartoszHudzik · X

RT @kaulcsmc: DAPA-MI A case of 'divining' a positive outcome with 'misuse' of Win Ratio! PEP driven by most prevalent but arguably least…

Nov 12, 2023 · 18 shares · 1,428 followers View post →

Soraya

@Sorayamutro · X

RT @SeguraCardio:

Nov 12, 2023 · 25 shares · 211 followers View post →

Jamie Wang

@jamiewang1228 · X

RT @CristobMorales: https://t.co/WX2zJrTTGH DAPAGLIFLOZIN IN MYOCARDIAL INFARCTION WITHOUT DIABETES OR HEART FAILURE @AHA23 @ValleAlfonso @…

Nov 12, 2023 · 12 shares · 9 followers View post →

Will Watson

@DrWillWatson · X

RT @kaulcsmc: DAPA-MI A case of 'divining' a positive outcome with 'misuse' of Win Ratio! PEP driven by most prevalent but arguably least…

Nov 12, 2023 · 18 shares · 3,324 followers View post →

Alessio G

@ptialex77 · X

RT @SeguraCardio:

Nov 12, 2023 · 25 shares · 653 followers View post →

Muhammad Tahir

@tauhair · X

RT @kaulcsmc: DAPA-MI A case of 'divining' a positive outcome with 'misuse' of Win Ratio! PEP driven by most prevalent but arguably least…

Nov 12, 2023 · 18 shares · 240 followers View post →

Leyre_G.

@leyre_gp · X

RT @SeguraCardio:

Nov 12, 2023 · 25 shares · 1,053 followers View post →

Raul Eduardo Reyes Toledo

@rauleduardore · X

RT @ZHeart11768530: “Dapagliflozin in #MI without #Diabetes or #HF”: https://t.co/qO9OSWLLWE DAPA-MI trial shows in non-diabetic pts with…

Nov 12, 2023 · 5 shares · 97 followers View post →

JORGE FERNANDEZ

@drjorfer · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 12, 2023 · 27 shares · 1,019 followers View post →

JORGE FERNANDEZ

@drjorfer · X

RT @CristobMorales: https://t.co/WX2zJrTTGH DAPAGLIFLOZIN IN MYOCARDIAL INFARCTION WITHOUT DIABETES OR HEART FAILURE @AHA23 @ValleAlfonso @…

Nov 12, 2023 · 12 shares · 1,019 followers View post →

Tatsuya Miyoshi

@Tatsu_Miyoshi · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 12, 2023 · 27 shares · 726 followers View post →

Rene Rodriguez

@renecardio4 · X

RT @SeguraCardio:

Nov 11, 2023 · 25 shares · 1,163 followers View post →

篤好

@absoluteC6 · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 158 followers View post →

Darth Kiki

@enriquegnzz · X

RT @SeguraCardio:

Nov 11, 2023 · 25 shares · 470 followers View post →

Taro Shiga, MD, PhD

@OncoCard_Ganken · X

RT @SeguraCardio:

Nov 11, 2023 · 25 shares · 1,028 followers View post →

Rizki

@rizrasmin · X

RT @SeguraCardio:

Nov 11, 2023 · 25 shares · 27 followers View post →

Dr. Shashank Joshi

@AskDrShashank · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 32,514 followers View post →

Dr. Shashank Joshi

@AskDrShashank · X

RT @kaulcsmc: DAPA-MI A case of 'divining' a positive outcome with 'misuse' of Win Ratio! PEP driven by most prevalent but arguably least…

Nov 11, 2023 · 18 shares · 32,514 followers View post →

Berhans

@pprabin500 · X

RT @SeguraCardio:

Nov 11, 2023 · 25 shares · 140 followers View post →

小板橋紀通 Nori Koitabashi

@GunmaUnivNKoita · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 1,641 followers View post →

Abhishek

@aksrulz13 · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 623 followers View post →

Yoga Yudhistira

@yudhistirayoga_ · X

RT @CristobMorales: https://t.co/WX2zJrTTGH DAPAGLIFLOZIN IN MYOCARDIAL INFARCTION WITHOUT DIABETES OR HEART FAILURE @AHA23 @ValleAlfonso @…

Nov 11, 2023 · 12 shares · 25 followers View post →

Carlos F. Matute-Martínez

@Felipe_Matute · X

Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure | NEJM Evidence https://t.co/CDkczTuHpI

Nov 11, 2023 · 215 followers View post →

Dr. FEVI

@javier20ch · X

Nov 11, 2023 · 2 likes · 1 share · 13,417 followers View post →

Joel Navarrete

@JoelNavaGar · X

RT @SeguraCardio:

Nov 11, 2023 · 25 shares · 68 followers View post →

Adil Rashid MD

@adil_rashidk · X

RT @kaulcsmc: DAPA-MI A case of 'divining' a positive outcome with 'misuse' of Win Ratio! PEP driven by most prevalent but arguably least…

Nov 11, 2023 · 18 shares · 1,452 followers View post →

Rosa Fernandez

@MAROSFO · X

RT @CristobMorales: https://t.co/WX2zJrTTGH DAPAGLIFLOZIN IN MYOCARDIAL INFARCTION WITHOUT DIABETES OR HEART FAILURE @AHA23 @ValleAlfonso @…

Nov 11, 2023 · 12 shares · 3,310 followers View post →

Alejandra Fernández

@AleFer_endo · X

RT @CristobMorales: https://t.co/WX2zJrTTGH DAPAGLIFLOZIN IN MYOCARDIAL INFARCTION WITHOUT DIABETES OR HEART FAILURE @AHA23 @ValleAlfonso @…

Nov 11, 2023 · 12 shares · 719 followers View post →

Sol

@ArualSogar · X

RT @SeguraCardio:

Nov 11, 2023 · 25 shares · 794 followers View post →

EstiUgarte

@EstiUgarte · X

RT @CristobMorales: https://t.co/WX2zJrTTGH DAPAGLIFLOZIN IN MYOCARDIAL INFARCTION WITHOUT DIABETES OR HEART FAILURE @AHA23 @ValleAlfonso @…

Nov 11, 2023 · 12 shares · 1,491 followers View post →

Alfonso Valle

@ValleAlfonso · X

RT @CristobMorales: https://t.co/WX2zJrTTGH DAPAGLIFLOZIN IN MYOCARDIAL INFARCTION WITHOUT DIABETES OR HEART FAILURE @AHA23 @ValleAlfonso @…

Nov 11, 2023 · 12 shares · 21,708 followers View post →

lal0155

@lal0155 · X

RT @SeguraCardio:

Nov 11, 2023 · 25 shares · 12 followers View post →

EOLO MORANDI JR.

@eolojr · X

RT @SeguraCardio:

Nov 11, 2023 · 25 shares · 538 followers View post →

JorgeEdoChava75

@QicenoJorge · X

RT @SeguraCardio:

Nov 11, 2023 · 25 shares · 999 followers View post →

CardioAcademic

@CardioAcademic · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 3,220 followers View post →

mocchi

@mocchi_ym · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 212 followers View post →

Cristobal Morales

@CristobMorales · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 17,046 followers View post →

Cristobal Morales

@CristobMorales · X

https://t.co/WX2zJrTTGH DAPAGLIFLOZIN IN MYOCARDIAL INFARCTION WITHOUT DIABETES OR HEART FAILURE @AHA23 @ValleAlfonso @almucastro01 @miriamsandin @MAROSFO https://t.co/A4LabBrOCD

Nov 11, 2023 · 34 likes · 12 shares · 17,046 followers View post →

Dr Shailesh Singh

@drShaileshSingh · X

4⃣ The study also confirms dapagliflozin's safety in this patient population. you can read the trial https://t.co/wtQkIVFIAt

Nov 11, 2023 · 6,112 followers View post →

Brendon Neuen

@brendonneuen · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 4,668 followers View post →

EOLO MORANDI JR.

@eolojr · X

RT @kaulcsmc: DAPA-MI A case of 'divining' a positive outcome with 'misuse' of Win Ratio! PEP driven by most prevalent but arguably least…

Nov 11, 2023 · 18 shares · 538 followers View post →

Kavitha Naresh

@cavy301 · X

RT @aklfahed: DAPA-MI #AHA2023 Dapagliflozin in secondary CVD prevention Patients post acute MI + impaired LVEF but no DM/HF Registry-b…

Nov 11, 2023 · 2 shares · 704 followers View post →

@Heart_Team

@Heart_Team1 · X

RT @SeguraCardio:

Nov 11, 2023 · 25 shares · 448 followers View post →

Coronary 4Front

@Coronary4front · X

RT @kaulcsmc: DAPA-MI A case of 'divining' a positive outcome with 'misuse' of Win Ratio! PEP driven by most prevalent but arguably least…

Nov 11, 2023 · 18 shares · 1,772 followers View post →

Dr Carlos Mogollon

@DrMogollonC · X

Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure | NEJM Evidence https://t.co/RgmMZBkFi0

Nov 11, 2023 · 107 followers View post →

Jose G. Aray G.

@drjarayg · X

RT @SeguraCardio: https://t.co/Az2xYywwJ1

Nov 11, 2023 · 1 share · 1,143 followers View post →

Diego Segura-Rodríguez

@SeguraCardio · X

https://t.co/Az2xYywwJ1

Nov 11, 2023 · 5 likes · 1 share · 25,748 followers View post →

Diego Segura-Rodríguez

@SeguraCardio · X

Nov 11, 2023 · 86 likes · 25 shares · 25,748 followers View post →

Paul Forsyth

@PharmacistHF · X

RT @kaulcsmc: DAPA-MI A case of 'divining' a positive outcome with 'misuse' of Win Ratio! PEP driven by most prevalent but arguably least…

Nov 11, 2023 · 18 shares · 3,741 followers View post →

Carlos Ortiz Bautista

@Carlos_Ortiz85 · X

RT @ZHeart11768530: “Dapagliflozin in #MI without #Diabetes or #HF”: https://t.co/qO9OSWLLWE DAPA-MI trial shows in non-diabetic pts with…

Nov 11, 2023 · 5 shares · 513 followers View post →

Dr. Martha Gulati ♥️

@DrMarthaGulati · X

RT @kaulcsmc: DAPA-MI A case of 'divining' a positive outcome with 'misuse' of Win Ratio! PEP driven by most prevalent but arguably least…

Nov 11, 2023 · 18 shares · 64,736 followers View post →

Dan Jones

@Bhcintervention · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 1,934 followers View post →

Dr. Nazifa Kadery, PharmD, RPh

@dose_of_naz · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 254 followers View post →

Maggie Simpson

@m4ggiesimpson · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 4,388 followers View post →

Habib Cissé

@Kissiland_man · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 893 followers View post →

Javed Alloo

@javedalloo · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 1,945 followers View post →

Chidambara .ML.

@chidambara09 · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 11,712 followers View post →

Hikmet Kadıoğlu

@HikmetKadi · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 201 followers View post →

Takahiro Suzuki MD MPH

@SuzukiTtweet · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 580 followers View post →

Boback Ziaeian

@boback · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 3,362 followers View post →

Mehriban Isgandar

@MehribanIsgand1 · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 221 followers View post →

ナマケモノ

@namake_mono1024 · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 80 followers View post →

高麗謙吾@心臓

@ken_korai · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 11,141 followers View post →

Professor Vijay Kunadian

@VijayKunadian · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 5,048 followers View post →

Victor G. Aldana

@vgaldana · X

Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure | NEJM Evidence #AHA23 ⁦@AHAScience⁩ ⁦@sccccardio⁩ ⁦@SIAC_cardio⁩ https://t.co/rHUWlqH0U7

Nov 11, 2023 · 2 likes · 670 followers View post →

Daniel Santana

@DQwerty92 · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 494 followers View post →

NEJM

@NEJM · X

RT @NEJMEvidence: Presented at #AHA23: “Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure” by Stefan James, MD, PhD…

Nov 11, 2023 · 27 shares · 935,676 followers View post →

NEJM Evidence

@NEJMEvidence · X

Nov 11, 2023 · 101 likes · 27 shares · 30,915 followers View post →

Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure.

Mentions per month

Where it's discussed

What people are saying

Abstract in brief

Top posts

All mentions

ESC Guidelines for Cardiovascular Diseases in Diabetes Management

Top Clinical Papers of November 2023 in Cardiology

Cardiology Advances: Dapagliflozin's Impact Post-Myocardial Infarction